/Companies

Proteinea

Founded 2020 · 51 employees on LinkedIn · 6 known investors

Find your way into Proteinea

Sign up to see every warm intro you have to Proteinea

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Proteinea team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.

Founders & leadership

Proteinea was founded in 2020 by Abdulaziz Elgammal and Mahmoud Eljendy.

AEAbdulaziz Elgammal
Abdulaziz ElgammalCo-founder & CPO
MEMahmoud Eljendy
Mahmoud EljendyCo-Founder & CEO

Investors · 6

Frequently asked questions

What does Proteinea do?
Proteinea uses proprietary AI models and computational tools to engineer antibodies, focusing on rational design of antibody Fc domains for improved efficacy, half-life, and targeted biodistribution. It combines AI-driven design frameworks with wet-lab validation to develop Fc-optimized antibody scaffolds for therapeutic development.
Who founded Proteinea?
Proteinea was founded by Abdulaziz Elgammal, Mahmoud Eljendy in 2020.
Who are Proteinea's investors?
Proteinea's investors include 500 Global, Sadu Capital, Sawari Ventures, Shorooq Partners, SOSV, VentureSouq.